Literature DB >> 8105310

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.

T W Meade1, V Ruddock, Y Stirling, R Chakrabarti, G J Miller.   

Abstract

Fibrinolytic activity (FA) was measured by dilute blood clot lysis time at entry to the Northwick Park Heart Study in 1382 white men aged 40-64, of whom 179 subsequently experienced episodes of ischaemic heart disease during a mean follow-up period of 16.1 years. There was a significant interaction between age and low FA (p = 0.02) with respect to ischaemic heart disease: a difference of one standard deviation in FA was associated with a difference of about 40% in ischaemic heart disease risk (p = 0.002) in those aged 40-54 at entry. The FA association remained after adjusting for plasma fibrinogen. High fibrinogen concentrations themselves were also associated with ischaemic heart disease, as was high factor VII activity with fatal events. Low FA in younger men may exert a long-term influence by impairing the removal of fibrin deposits that contribute to atherogenesis. Low FA appears to be a leading determinant of ischaemic heart disease in younger men and methods of enhancing fibrinolytic activity, whether by life-style changes or pharmacologically, should be considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105310     DOI: 10.1016/0140-6736(93)92062-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  75 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

Review 2.  Exercise in cardiac rehabilitation.

Authors:  H J Bethell
Journal:  Br J Sports Med       Date:  1999-04       Impact factor: 13.800

3.  Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: global fibrinolytic capacity.

Authors:  Abdullah Dogan; Bahattin Tunc; Oktay Ergene; Mehmet Ozaydin; Cem Nazli; Ahmet Altinbas; Omer Gedikli
Journal:  Int J Cardiovasc Imaging       Date:  2003-12       Impact factor: 2.357

Review 4.  [Non-lipid effects of statins: myth or fact?].

Authors:  Eleonora Urbauer; Christian Joukhadar
Journal:  Wien Med Wochenschr       Date:  2003

Review 5.  Coagulability in obstructive sleep apnea.

Authors:  Christina Liak; M Fitzpatrick
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

6.  Thrombophilia in Patients with Hypertriglyceridemia.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 7.  Treatment of the metabolic syndrome: the impact of lifestyle modification.

Authors:  Allison M Pritchett; John P Foreyt; Douglas L Mann
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

8.  Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.

Authors:  Folkert W Asselbergs; Scott M Williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; Gerjan Navis; Douglas E Vaughan; Wiek H van Gilst; Jason H Moore
Journal:  Genomics       Date:  2007-01-05       Impact factor: 5.736

9.  The effect of acute aerobic exercise on hemostasis in obstructive sleep apnea.

Authors:  Ryan A Martin; Courtney Strosnider; Gabrielle Giersch; Christopher J Womack; Trent A Hargens
Journal:  Sleep Breath       Date:  2017-02-14       Impact factor: 2.816

Review 10.  Heart and mind: (1) relationship between cardiovascular and psychiatric conditions.

Authors:  S U Shah; A White; S White; W A Littler
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.